课题基金 / 基金详情

EDGE CT: Genetic tools to study giant viruses

EDGE CT: Genetic tools to study giant viruses
EDGE CT:研究巨型病毒的遗传工具
批准号:
1922958
负责人:
Steven Wilhelm
金额:
$100.93万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-10-01 至 2024-09-30

项目摘要

项目成果

Steven Wilhelm的其他基金

相似基金

相关文献

中文摘要
翻译
近年来,微生物学家已经意识到大量的感染原生生物的“巨型病毒”。这些病毒也被认为是多细胞生物微生物组的组成部分。这些巨型生物中的许多基因被认为是病毒的新基因:许多基因编码的过程只与“活细胞生物体”有关,如DNA复制或DNA修复,在这些病毒中发现。研究表明,这些巨型病毒已经从所有生物中收集了这些基因,使这些病毒的基因组充其量可以被描述为马赛克。 此外,在巨型病毒中发现的数百种基因中,有许多对科学来说仍然是全新的。 尽管有如此丰富的信息,我们仍然没有工具来研究这些巨大的病毒基因是如何发挥作用的,或者它们是否是必要的。 这项研究将开发在一个模型巨型病毒系统(Aureococcus anophagefferens病毒)中进行遗传研究所需的工具,并建立这些工具集扩展到其他巨型病毒及其宿主的能力。这些病毒含有编码过程的功能基因,这些过程可以包括光依赖性和独立的DNA修复、糖代谢基因和与翻译过程相关的基因。系统发育学研究表明,这些基因是通过猖獗的水平基因转移收集的。 这项研究将开发所需的协议,以测试基因的功能和活性在一个巨大的病毒(AaV)感染的浮游植物Aureococcus anophagefferens。AaV是Mimiviridae的成员,是一种具有复杂基因互补的大型病毒。 PI和受训人员将开发体外方法来修饰和转化AaV,包括引入抗生素抗性和/或显色/荧光蛋白,以进行遗传上易于处理的选择,用于随后的基因替代研究。 PI将测试其他感染藻类的Mimiviridae和Phycodnaviridae的协议,以确定其他巨型病毒宿主系统的可处理性。 沿着对博士后、研究生和本科生的培训,该项目将开发允许在随后的研究中进行假设驱动测试的工具,在该系统中,许多(60%)基因产物被注释为假设。该项目将通过培训课程和专门的研讨会传达协议,并通过protocols.io以开放获取的方式记录所有方法。 学生记者将制作供公众消费的材料,包括关注病毒在生态学中的积极作用、技术再现性在科学中的重要性的短视频,以及一些关于巨型病毒迷人本质的视频。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
Non-Technical Abstract In recent years microbiologists have become aware of abundant "giant viruses" that infect protists. These viruses have also been implicated as components of the microbiomes of multicellular organisms. Many of the genes within these giants are considered novel for viruses: many genes encode for processes only associated with "living cellular organisms," like DNA replication or DNA repair, are found in these viruses. Studies suggest that these giant viruses have collected these genes from across all biology, leaving these viruses with genomes that can at best be described as mosaics. Moreover many of the hundreds of genes found in giant viruses remain completely new to science. In spite of this obvious wealth of information, we remain without tools to study how these giant virus genes function or if they are even necessary. This study will develop the tools needed to do genetic research in a model giant virus system (the Aureococcus anophagefferens Virus) and establish the ability of these tool sets to be extended to other giant viruses and their hosts.Technical AbstractWhile discovered only 15 years ago, giant viruses infecting protists have been shown to be distributed across ecosystems. These viruses contain functional genes encoding processes that can include light-dependent and independent DNA repair, sugar metabolism genes and genes associated with the process of translation. Phylogenetic examinations suggest these genes have been collected by rampant horizontal gene transfer. This study will develop protocols required to test gene function and activity in a giant virus (AaV) that infects the pelagophyte Aureococcus anophagefferens. A member of the Mimiviridae, AaV is a large virus with a complex complement of genes. The PIs and trainees will develop in vitro approaches to modify and transform AaV, including the introduction of antibiotic resistance and/or chromogenic/fluorogenic proteins for genetically tractable selections for use in subsequent gene replacement studies. The PIs will test protocols on other Mimiviridae and Phycodnaviridae that infect algae to determine tractability in other giant virus-host systems. Along with training of a postdoc, graduate and undergraduate students, this project will develop tools that allow for hypothesis driven testing in subsequent studies in a system where many ( 60%) of the gene products are annotated as hypothetical. The project will communicate protocols through training sessions as well as a dedicated workshop, and document all approaches in open access through protocols.io. Student journalists will produce material for public consumption, including short videos focusing on the positive role of viruses in ecology, the importance of technical reproducibility in science, and several on the fascinating nature of giant viruses.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fmicb.2020.00492
发表时间: 2020-03
期刊: Frontiers in Microbiology
影响因子: 5.2
作者: [Eric R. Gann;B. Hughes;Todd B. Reynolds;S. Wilhelm]
通讯作者: Eric R. Gann;B. Hughes;Todd B. Reynolds;S. Wilhelm
DOI: 10.1111/jpy.13221
发表时间: 2021-12-14
期刊: JOURNAL OF PHYCOLOGY
影响因子: 2.9
作者: [Gann, Eric R., Truchon, Alexander R., Wilhelm, Steven W.]
通讯作者: Wilhelm, Steven W.
REU Site: Microbial community interactions and functions
  • 批准号:
    2050743
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $40.23万
  • 财政年份:
    2021
  • 负责人:
    Steven Wilhelm
  • 依托单位:
Collaborative Research: Inferring Cellular Lysis and Regeneration of Organic Matter by Marine Viruses
  • 批准号:
    1829641
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $59.84万
  • 财政年份:
    2018
  • 负责人:
    Steven Wilhelm
  • 依托单位:
REU Site: Microbial community interactions and functions
  • 批准号:
    1659599
  • 项目类别:
    Standard Grant
  • 资助金额:
    $34.04万
  • 财政年份:
    2017
  • 负责人:
    Steven Wilhelm
  • 依托单位:
Collaborative Research: An Integrated Approach to Understanding the Function of the Potent Hepatotoxin Microcystin in the Growth & Ecology of Microcystis
  • 批准号:
    1451528
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $71.94万
  • 财政年份:
    2015
  • 负责人:
    Steven Wilhelm
  • 依托单位:
国内基金
海外基金
沙眼衣原体感染入侵新机制:通过T3SS效应蛋白CT622与ARP2相互作用介导宿主细胞质膜重塑
  • 批准号:
    2026JJ50576
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    雷文波
  • 依托单位:
基于深度卷积神经网络的的胸腺CT影像特征挖掘及可解释性胸腺瘤相关重症肌无力诊疗预测模型构建研究
  • 批准号:
    2026JJ50300
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周昊
  • 依托单位:
基于增强CT影像组学机器学习算法在鉴别胃肠间质瘤KIT外显子11、9突变及PDGFRA 突变的多模态研究
  • 批准号:
    2026JJ82481
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈晨
  • 依托单位:
基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
  • 批准号:
    2026JJ81876
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    戴嘉舜
  • 依托单位: